Preoperative and Postoperative Opiate Use by the Arthroplasty Patient

Journal of Arthroplasty

Volumn 31, Issue 10, 2016, Pages 2081-2084

  Zarling, Bradley J ^a   Yokhana, Sanar S ^b   Herzog, Darren T ^a   Markel, David C ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b Providence Providence Park Hospital   (United States)

Author keywords

arthroplasty; Michigan Automated Prescription System; narcotic prescriptions; opiate use; postoperative narcotics

Indexed keywords

COCODAMOL; FENTANYL; HYDROCODONE BITARTRATE PLUS PARACETAMOL; MORPHINE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL COST; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGEON; PHYSICIAN; POSTOPERATIVE CARE; POSTOPERATIVE PAIN; PREOPERATIVE TREATMENT; PRESCRIPTION; TOTAL HIP PROSTHESIS; TOTAL KNEE ARTHROPLASTY; ADVERSE EFFECTS; ARTHRALGIA; COMPLICATION; HIP REPLACEMENT; KNEE; KNEE REPLACEMENT; MIDDLE AGED; OSTEOARTHRITIS; PAIN, POSTOPERATIVE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ARTHRALGIA; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OPIATE ALKALOIDS; OSTEOARTHRITIS; PAIN, POSTOPERATIVE; PATIENT DISCHARGE; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES;

EID: 84965036345     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2016.03.061     Document Type: Article

References (19)

1. 1 Buttgereit, F., Burmester, G.-R., Bijlsma, J.W.J., Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?. RMD Open, 1(1), 2015, e000027.
2. 2 Hawker, G., Update on the epidemiology of the rheumatic diseases. Curr Opin Rheumatol, 9(2), 1997, 90.
3. 3 Lawrence, R.C., Felson, D.T., Helmick, C.G., et al., National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum, 58(1), 2008, 26.
4. 4 Wang, M., Shen, J., Jin, H., et al. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis. Ann New York Acad Sci, 1240, 2011, 61.
5. 5 Lane, N.E., Thompson, J.M., Management of osteoarthritis in the primary-care setting: an evidence-based approach to treatment. Am J Med, 103(6A), 1997, 25S.
6. 6 Reginster, J.Y., Khaltaev, N.G., Introduction and WHO perspective on the global burden of musculoskeletal conditions. Rheumatology (Oxford, England), 41(Supp 1), 2002, 1.
7. 7 Kotlarz, H., Gunnarsson, C.L., Fang, H., et al. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum, 60(12), 2009, 3546.
8. 8 Jones, B.Q., Covey, C.J., Sineath, M.H., Nonsurgical management of knee pain in adults. Am Fam Physician, 92(10), 2015, 875.
9. 9 Goodwin, J.L.R., Kraemer, J.J., Bajwa, Z.H., The use of opioids in the treatment of osteoarthritis: when, why, and how?. Curr Rheumatol Rep, 11(1), 2009, 5.
10. 10 Jevsevar, D.S., Brown, G.A., Jones, D.L., et al., American Academy of Orthopaedic Surgeons. The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J Bone Joint Surg Am, 95(20), 2013, 1885.
11. 11 Sanders, J.O., Heggeness, M.H., Murray, J., et al. The American Academy of Orthopaedic Surgeons Appropriate Use Criteria on the non-arthroplasty treatment of osteoarthritis of the knee. J Bone Joint Surg Am, 96(14), 2014, 1220.
12. 12 Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses—a U.S. epidemic. MMWR Morbidity Mortality Weekly Rep, 61(1), 2012, 10.
13. 13 Petre, B.M., Roxbury, C.R., McCallum, J.R., et al. Pain reporting, opiate dosing, and the adverse effects of opiates after hip or knee replacement in patients 60 years old or older. Geriatr Orthopaedic Surg Rehabil, 3(1), 2012, 3.
14. 14 Holman, J.E., Stoddard, G.J., Higgins, T.F., Rates of prescription opiate use before and after injury in patients with orthopaedic trauma and the risk factors for prolonged opiate use. J Bone Joint Surg Am Volume, 95(12), 2013, 1075.
15. 15 Kurtz, S., Ong, K., Lau, E., et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am Volume, 89(4), 2007, 780.
16. 16 Agarin, T., Trescot, A.M., Agarin, A., et al. Reducing opioid analgesic deaths in America: what health providers can do. Pain Physician, 18(3), 2015, E307.
17. 17 O'Connor, M.I., Sex differences in osteoarthritis of the hip and knee. J Am Acad Orthopaedic Surgeons, 15(Suppl 1), 2007, S22.
18. 18 Ramos, N.L., Karia, R.J., Hutzler, L.H., et al. The effect of discharge disposition on 30-day readmission rates after total joint arthroplasty. J Arthroplasty, 29(4), 2014, 674.
19. 19 Pivec, R., Issa, K., Naziri, Q., et al. Opioid use prior to total hip arthroplasty leads to worse clinical outcomes. Int Orthopaedics, 38(6), 2014, 1159.